Researchers examined the extent to which pharmaceutical industry marketing of opioid products to physicians during 2014 correlated with opioid prescribing in 2015.
Industry gifts were found to largely influence prescribing behavior, which can have adverse public health implications.
Medicaid's best-price rule is not as serious a problem as drug manufacturers imply, although it may affect novel pricing arrangements.
Most physicians on Twitter with a financial conflict of interest and frequent tweets mention specific drugs for which they have a conflict.
One physician shares his insights on the culture of overprescribing medications and how prescribing habits are reflective of swindling by the pharmaceutical industry
When it comes to receiving payments from pharmaceutical companies, it's not always the size of the payment that matters.
About half of U.S. doctors received payments from the pharmaceutical and medical device industries in 2015.
Congress will now be addressing the problem of antibiotic resistance with a bill introduced to the US House of Representatives on March 30, 2017.
Clinical Pain Advisor Articles
- Serum Vitamin D Levels and Risk for Migraine
- Rimegepant Orally Dissolving Formulation Provides Rapid Relief From Acute Migraine
- Updated Evidence-Based Recommendations for Buprenorphine Treatment
- Business Degree Increasingly Useful for Doctors
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Manual Therapy vs Opioids for Management of Shoulder, Spine Pain
- Greater Temporal Summation of Pain in HIV With Chronic Pain
- FDA Warns Two Companies About Bogus Opioid Addiction Treatment
- A Potential Biomarker for Predicting Antibody Treatment Efficacy in Migraine
- Anomalous Times and Billing Practices of Anesthesia Practitioners Examined